HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: ERC-09-0086v1 16/4/1073    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Welboren, W.-J. Articles by Stunnenberg, H. G PubMed PubMed Citation Articles by Welboren, W.-J. Articles by Stunnenberg, H. G

Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, PO Box 9101, HB Nijmegen, The Netherlands Departments of
¹ , Chemical Endocrinology
² Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

(Correspondence should be addressed to H G Stunnenberg; Email: h.stunnenberg{at}ncmls.ru.nl)

The estrogen receptor (ER) is a ligand-dependent transcription factor that regulates a large number of genes in many different target tissues and is important in the development and progression of breast cancer. ER-mediated transcription is a complex process regulated at many different levels. The interplay between ligand, receptor, DNA sequence, cofactors, chromatin context, and post-translational modifications culminates in transcriptional regulation by ER. Recent technological advances have allowed the identification of ER target genes on a genome-wide scale. In this review, we provide an overview of the progress made in our understanding of the different levels of regulation mediated by ER. We discuss the recent advances in the identification of the ER-binding sites and target gene network and their clinical applications.